Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO? - Wikidata - awgldk - TriplyDB

Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?

Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?

http://www.wikidata.org/entity/Q28552094

about

DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting.Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities "Life continues": Patient, health care and community care workers perspectives on self-administered treatment for rifampicin-resistant tuberculosis in Khayelitsha, South Africa

P2860

Q33704314-749EEA65-8F48-4385-9756-0A5F6CC03F1F Q58571940-D15FC09D-DF9C-4129-836B-FA4CAFB6EB38 Q58741213-FFD03FEE-4659-4454-839A-F812CF1674E1

P2860

Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?

http://www.wikidata.org/entity/Q28552094

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?

@ast

Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?

@en

Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?

@nl

type

label

Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?

@ast

Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?

@en

Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?

@nl

prefLabel

Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?

@ast

Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?

@en

Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?

@nl

P1433

Q28552094-842EF6BD-7631-49B7-A479-B2DE49278B4D

P1476

Q28552094-A8D4E71C-A8CE-4CF6-B5B5-18BD5241D67F

P2093

Q28552094-107E7F8D-15A3-485F-9B34-3AF0EE3CC379

Q28552094-1AC8264D-3B6D-4F43-B937-C55E866D4CFC

Q28552094-208F8A54-ABE4-45FB-99DB-59FFE470B86E

Q28552094-82BF2162-39F0-406B-BBAB-3DCD85631B05

Q28552094-930BCEB1-738E-42AF-873B-86621084EB1A

P2860

Q28552094-07828B95-445F-4598-A207-E2AAEF5ED1F4

Q28552094-0A7F8E21-B91A-46B6-B81F-0F48D9A5B4EF

Q28552094-134CAC9E-A8A8-41AB-A926-65B33368F03A

Q28552094-1E5DD512-F072-4AC9-9704-543A04A4083F

Q28552094-2A3CE12D-9916-49FE-ADCB-57568E49DD00

Q28552094-44A2B463-01C2-4242-A729-692A828CA5E9

Q28552094-C6FAC48C-046D-4584-B2FD-5DA34C779F40

Q28552094-D584ABFD-35BA-48F5-B975-0DE7AD4167F0

P304

Q28552094-F8CB52EA-07A4-49D5-BD03-910B189ED1A8

P31

Q28552094-BDDD0671-0C67-4639-8C66-F209F3C17286

P356

Q28552094-94AF52C5-3263-4790-87D3-EE585D9EB7D2

P407

Q28552094-908E90F3-D91B-40B2-A53B-82244DF5D63B

P433

Q28552094-30969130-E770-47D1-B3AB-F8DA58B2C12F

P478

Q28552094-ECF43AB5-8EF7-4C6F-A028-1FF788097E3B

P50

Q28552094-A97C0ACF-58D2-43EF-876E-7BE014016CC5

P577

Q28552094-64F1CBC2-3E0E-4A47-B661-9242FB3464F9

P5875

Q28552094-B668F53A-CBC4-4383-A5B4-85054B232EE4

P698

Q28552094-877F4C13-B9E6-448F-A6BB-23F79C37BCF6

P921

Q28552094-B94E437E-C591-4B71-986F-EF200252B433

P932

Q28552094-A87D66F9-4614-4851-9EA6-8DD89565891C

P356

JOURNAL.PONE.0144936

P1433

P1476

Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?

@en

P2093

Jennifer Furin

http://www.w3.org/2001/XMLSchema#string

Mrinalini Das

http://www.w3.org/2001/XMLSchema#string

Sonakshi Jadhav

http://www.w3.org/2001/XMLSchema#string

Stella Benbaba

http://www.w3.org/2001/XMLSchema#string

Tony Reid

http://www.w3.org/2001/XMLSchema#string

P2860

Directly observed therapy for treating tuberculosis

A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients

Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV co-infected patients in South Africa.

Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study.

Community-based directly observed therapy (DOT) versus clinic DOT for tuberculosis: a systematic review and meta-analysis of comparative effectiveness.

Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis.

Effectiveness of DOT for tuberculosis treatment outcomes: a prospective cohort study in Bangkok, Thailand.

'I cry every day': experiences of patients co-infected with HIV and multidrug-resistant tuberculosis.

P304

e0144936

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0144936

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Petros Isaakidis

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

288817306

http://www.w3.org/2001/XMLSchema#string

P698

26713873

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

4703099

http://www.w3.org/2001/XMLSchema#string